Geeta Datta

3.1k total citations
63 papers, 2.6k citations indexed

About

Geeta Datta is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Geeta Datta has authored 63 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 21 papers in Surgery and 20 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Geeta Datta's work include Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers), Cholesterol and Lipid Metabolism (12 papers) and Lipoproteins and Cardiovascular Health (11 papers). Geeta Datta is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers), Cholesterol and Lipid Metabolism (12 papers) and Lipoproteins and Cardiovascular Health (11 papers). Geeta Datta collaborates with scholars based in United States, India and Canada. Geeta Datta's co-authors include David W. Garber, G.M. Anantharamaiah, Mohamad Navab, Alan M. Fogelman, Manjula Chaddha, Mayakonda N. Palgunachari, G.M. Anantharamaiah, Susan Hama, C. Roger White and Srinivasa T. Reddy and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Circulation Research.

In The Last Decade

Geeta Datta

62 papers receiving 2.6k citations

Peers

Geeta Datta
Nassrin Dashti United States
Shangzhe Xu United States
Lita A. Freeman United States
Richard J. Pease United Kingdom
Geeta Datta
Citations per year, relative to Geeta Datta Geeta Datta (= 1×) peers Mayakonda N. Palgunachari

Countries citing papers authored by Geeta Datta

Since Specialization
Citations

This map shows the geographic impact of Geeta Datta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geeta Datta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geeta Datta more than expected).

Fields of papers citing papers by Geeta Datta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geeta Datta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geeta Datta. The network helps show where Geeta Datta may publish in the future.

Co-authorship network of co-authors of Geeta Datta

This figure shows the co-authorship network connecting the top 25 collaborators of Geeta Datta. A scholar is included among the top collaborators of Geeta Datta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geeta Datta. Geeta Datta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
White, C. Roger, Geeta Datta, Landon Wilson, Mayakonda N. Palgunachari, & G.M. Anantharamaiah. (2019). The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage. Chemistry and Physics of Lipids. 219. 28–35. 14 indexed citations
2.
Segrest, Jere P., Martin K. Jones, Andrea Catte, et al.. (2015). Surface Density-Induced Pleating of a Lipid Monolayer Drives Nascent High-Density Lipoprotein Assembly. Structure. 23(7). 1214–1226. 34 indexed citations
3.
Handattu, Shaila P., Gaurav Nayyar, David W. Garber, et al.. (2012). Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice. Atherosclerosis. 227(1). 58–64. 31 indexed citations
4.
Datta, Geeta. (2011). HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated Rats. Journal of Clinical & Experimental Cardiology. 2(11). 21 indexed citations
5.
Dai, Lijun, Geeta Datta, Zhenghao Zhang, et al.. (2010). The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats. Journal of Lipid Research. 51(9). 2695–2705. 49 indexed citations
6.
Handattu, Shaila P., Geeta Datta, Richard M. Epand, et al.. (2010). Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice. Journal of Lipid Research. 51(12). 3491–3499. 18 indexed citations
7.
Maheshwari, Akhil, Ashish Kurundkar, David R. Kelly, et al.. (2009). Epithelial cells in fetal intestine produce chemerin to recruit macrophages. American Journal of Physiology-Gastrointestinal and Liver Physiology. 297(1). G1–G10. 48 indexed citations
8.
Datta, Geeta, C. Roger White, Nassrin Dashti, et al.. (2009). Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH2. Atherosclerosis. 208(1). 134–141. 50 indexed citations
9.
Zhang, Zhenghao, Geeta Datta, Yun Zhang, et al.. (2009). Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats. American Journal of Physiology-Heart and Circulatory Physiology. 297(2). H866–H873. 67 indexed citations
10.
Datta, Geeta, Manjula Chaddha, Shaila P. Handattu, et al.. (2009). ApoE Mimetic Peptide Reduces Plasma Lipid Hydroperoxide Content with a Concomitant Increase in HDL Paraoxonase Activity. Advances in experimental medicine and biology. 660. 1–4. 9 indexed citations
11.
White, C. Roger, Geeta Datta, Zhenghao Zhang, et al.. (2008). HDL therapy for cardiovascular diseases: the road to HDL mimetics. Current Atherosclerosis Reports. 10(5). 405–412. 8 indexed citations
12.
Anantharamaiah, G.M., Vinod Mishra, David W. Garber, et al.. (2007). Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides. Journal of Lipid Research. 48(9). 1915–1923. 100 indexed citations
13.
Handattu, Shaila P., David W. Garber, Dawn Horn, et al.. (2006). ApoA-I Mimetic Peptides with Differing Ability to Inhibit Atherosclerosis Also Exhibit Differences in Their Interactions with Membrane Bilayers. Journal of Biological Chemistry. 282(3). 1980–1988. 29 indexed citations
14.
Anantharamaiah, G.M., Mohamad Navab, Srinivasa T. Reddy, et al.. (2006). Synthetic peptides: managing lipid disorders. Current Opinion in Lipidology. 17(3). 233–237. 10 indexed citations
15.
Garber, David W., Shaila P. Handattu, Geeta Datta, et al.. (2006). Atherosclerosis and Vascular Disease: Effects of Peptide Mimetics of Apolipoproteins. Current Pharmaceutical Biotechnology. 7(4). 235–240. 9 indexed citations
16.
Navab, Mohamad, G.M. Anantharamaiah, Srinivasa T. Reddy, et al.. (2006). Potential clinical utility of high-density lipoprotein-mimetic peptides. Current Opinion in Lipidology. 17(4). 440–444. 22 indexed citations
17.
Reddy, Srinivasa T., G.M. Anantharamaiah, Mohamad Navab, et al.. (2005). Oral amphipathic peptides as therapeutic agents. Expert Opinion on Investigational Drugs. 15(1). 13–21. 20 indexed citations
18.
Datta, Geeta, Raquel F. Epand, Richard M. Epand, et al.. (2004). Aromatic Residue Position on the Nonpolar Face of Class A Amphipathic Helical Peptides Determines Biological Activity. Journal of Biological Chemistry. 279(25). 26509–26517. 64 indexed citations
19.
Navab, Mohamad, G.M. Anantharamaiah, Srinivasa T. Reddy, et al.. (2004). Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal. Current Opinion in Lipidology. 15(6). 645–649. 67 indexed citations
20.
Datta, Geeta & Anthony T. Tu. (1997). Structure and other chemical characterizations of gila toxin, a lethal toxin from lizard venom. Journal of Peptide Research. 50(6). 443–450. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026